loxoprofen has been researched along with Retroperitoneal Fibrosis in 1 studies
loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.
Retroperitoneal Fibrosis: A slowly progressive condition of unknown etiology, characterized by deposition of fibrous tissue in the retroperitoneal space compressing the ureters, great vessels, bile duct, and other structures. When associated with abdominal aortic aneurysm, it may be called chronic periaortitis or inflammatory perianeurysmal fibrosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amiya, E | 1 |
| Ishizaka, N | 1 |
| Watanabe, A | 1 |
| Endo, Y | 1 |
| Itou, R | 1 |
| Yoshida, S | 1 |
| Nangaku, M | 1 |
| Nagai, R | 1 |
1 other study available for loxoprofen and Retroperitoneal Fibrosis
| Article | Year |
|---|---|
Retroperitoneal fibrosis with periaortic and pericardial involvement.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Hormonal; Aorta; Humans; Male; | 2005 |